AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
QIAGEN announces the conversion price of new net share settled convertible bonds due 2032. The initial conversion price is set at $64.6338 per share, representing a premium of 40% above the reference share price of $46.1670 per share. The expected settlement date is September 4, 2025. QIAGEN will use the net proceeds for general corporate purposes, including refinancing existing indebtedness.

Daily stocks & crypto headlines, free to your inbox
Comments
No comments yet